Please wait while the formulary information is being retrieved.
TICANASE (FLUTICASONE PROPIONATE/SODIUM CHLORIDE/SODIUM BICARBONATE)
50 mcg-0.9 % kit, spray suspension and spray
- Dosage information is not available
50 mcg-0.9 % kit, spray suspension and spray
- Dosage information is not available
- None
Contraindicated
- boceprevir
- elvitegr-cobicist-emtric-tenof
- Incivek
- Kaletra
- Korlym
- lopinavir-ritonavir
- Mifeprex
- mifepristone
- Norvir
- Norvir Soft Gelatin
- ritonavir
- Stribild
- telaprevir
- Victrelis
Severe
Moderate
- amoxicil-clarithromy-lansopraz
- Biaxin
- Biaxin Xl
- Biaxin Xl Pak
- clarithromycin
- Erythrocin
- erythromycin
- erythromycin-sulfisoxazole
- itraconazole
- ketoconazole
- Omeclamox-pak
- omeprazole-clarith-amoxicillin
- Onmel
- Prevpac
- Sporanox
- Sporanox Pulsepak
- None
Contraindicated
- Active tuberculosis
- Measles
- Nasal septal perforation
- Nasal septal ulcers
- Nasal trauma
- Ocular herpes simplex
- Ocular hypertension
- Open angle glaucoma
- Operation on nose
- Varicella zoster virus infection
Severe
Moderate
- Adrenal cortical insufficiency
- Cataracts
- Epistaxis
- Inactive tuberculosis
- Nasal candidiasis
- Parasitic infection
TICANASE (FLUTICASONE PROPIONATE/SODIUM CHLORIDE/SODIUM BICARBONATE)
- None
- Dry nose
- Epistaxis
- Headache disorder
- Nasal passage irritation
- Pharyngitis
More Frequent
Severe
Less Severe
- Bronchitis
- Dizziness
- Lesion of nasal mucosa
- Urticaria
- Cough
- Crusted nasal mucosa
- Dysgeusia
- Fever
- Nasal congestion
- Nasal pain
- Nausea
- Rhinorrhea
- Sinusitis
- Sneezing
- Sore throat
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Adrenal cortical insufficiency
- Anaphylaxis
- Angioedema
- Cataracts
- Contact dermatitis
- Glaucoma
- Hypercortisolism
- Immunosuppression
- Impaired wound healing
- Nasal candidiasis
- Nasal septal perforation
- Pharyngeal candidiasis
- Skin rash
- Wheezing
Less Severe
- Abdominal pain with cramps
- Blurred vision
- Conjunctivitis
- Diarrhea
- Dry eye
- Flu-like symptoms
Contraindicated
None
Severe Precaution
Fluticasone Propionate (Nasal)
May slow growth rate. Safety and efficacy not established age less than 4 years.
- 1 Day – 4 Years
- May slow growth rate. Safety and efficacy not established age less than 4 years.
Management or Monitoring Precaution
Fluticasone Propionate(Nasal)
May reduce growth rate; monitor growth and use lowest effective dose.
- 4 Years – 18 Years
- May reduce growth rate; monitor growth and use lowest effective dose.
Fluticasone (nasal)
- Severity Level:
2
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Fluticasone (inhal, Nasal)
Systemic products excreted in rats; caution advised with nasal administration
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Systemic products excreted in rats; caution advised with nasal administration |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool